Видео ютуба по тегу Medicines: Bitopertin

Mechanism of action of bitopertin to treat patients with EPP
Mechanism of action of bitopertin to treat patients with EPP
Results from a murine model investigating bitopertin for the treatment of EPP
Results from a murine model investigating bitopertin for the treatment of EPP
BEACON trial results: safety & efficacy of bitopertin in adults with EPP
BEACON trial results: safety & efficacy of bitopertin in adults with EPP
Bitopertin UPdate with Dr. Bonkovsky
Bitopertin UPdate with Dr. Bonkovsky
Bitopertin | Wikipedia audio article
Bitopertin | Wikipedia audio article
bitopertin model overview
bitopertin model overview
Glycine Synthesis and its application in the negative symptoms of Schizophrenia #bitopertin
Glycine Synthesis and its application in the negative symptoms of Schizophrenia #bitopertin
Emerging therapies for EPP/XLP (erythropoietic protoporphyrias) by Prof Jean-Charles Deybach
Emerging therapies for EPP/XLP (erythropoietic protoporphyrias) by Prof Jean-Charles Deybach
This Medicine Packs A Sting (1946)
This Medicine Packs A Sting (1946)
Updates from the BRUIN study – long-term safety of pirtobrutinib in R/R MCL
Updates from the BRUIN study – long-term safety of pirtobrutinib in R/R MCL
A new type of medicine, custom-made with tiny proteins | Christopher Bahl
A new type of medicine, custom-made with tiny proteins | Christopher Bahl
Understanding life, advancing medicine
Understanding life, advancing medicine
Where Are We on the Path to Antipsychotic Treatment? A Little Old, A Little New/Feyza Arıcıoğlu (EN)
Where Are We on the Path to Antipsychotic Treatment? A Little Old, A Little New/Feyza Arıcıoğlu (EN)
05 53 - Novel treatments for schizophrenia: glycine Agonists + Transporter on glial cells inhibited.
05 53 - Novel treatments for schizophrenia: glycine Agonists + Transporter on glial cells inhibited.
The Ultimate Precision Medicine
The Ultimate Precision Medicine
Biosimilar Medicines - Lunch Time Presentation Part I
Biosimilar Medicines - Lunch Time Presentation Part I